• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病患者最重要的非运动症状有哪些?我们是否遗漏了这些症状?

What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them?

机构信息

Department of Clinical Neuroscience, Institute of Neurology, Royal Free Campus, London, United Kingdom.

出版信息

Mov Disord. 2010 Nov 15;25(15):2493-500. doi: 10.1002/mds.23394.

DOI:10.1002/mds.23394
PMID:20922807
Abstract

Nonmotor symptoms (NMS) are increasingly recognized as important and neglected aspects of Parkinson's disease (PD). We evaluated their relative frequency and comparative impact on health-related quality of life (Hr-QoL) using validated questionnaires. In addition, we assessed the rate of reporting of NMS in neurology clinics compared with their subjective impact on patients. We used a range of validated clinimetric scales of motor and nonmotor symptoms and Hr-QoL to assess consecutive patients with PD. Reporting of NMS was assessed by comparison with case note documentation. A mean of 11 of 30 NMS per patient were elicited on the NMS questionnaire of which on average 4.8 were reported in the clinical notes (44%). The most common NMS were autonomic (particularly urinary). The Hr-QoL scores correlated most strongly with autonomic dysfunction (r = 0.84; particularly urinary and gastrointestinal symptoms), mood (r = 0.74), fatigue (r = 0.74), sleep problems (nocturnal r = 0.55; daytime somnolence r = 0.65), pain (r = 0.56), and psychosis (r = 0.55, all p < 0.0001) followed by UPDRS motor score (r = 0.48, p < 0.0001). Greater motor fluctuations (r = 0.57) and dyskinesia (r = 0.43, both p < 0.0001) were also associated with worse Hr-QoL. In multivariate analysis, depression had the strongest association with Hr-QoL (adjusted R(2) = 0.53, p = 0.005) followed by fatigue, thermoregulatory, gastrointestinal, and cardiovascular autonomic function (especially orthostatic hypotension), daytime somnolence, and urinary problems. This study demonstrates that a autonomic dysfunction, psychiatric complications, pain, fatigue, and sleep problems are major correlates of poor Hr-QoL. However, whilst psychiatric problems are increasingly documented, many symptoms (particularly those possibly perceived as embarrassing or unrelated) remain under-reported.

摘要

非运动症状(NMS)日益被认为是帕金森病(PD)的重要且被忽视的方面。我们使用经过验证的问卷评估了它们的相对频率和对健康相关生活质量(Hr-QoL)的比较影响。此外,我们评估了神经病学诊所报告 NMS 的比率与其对患者的主观影响。我们使用一系列经过验证的运动和非运动症状及 Hr-QoL 的临床计量量表来评估连续的 PD 患者。通过与病历文档的比较来评估 NMS 的报告。在 NMS 问卷中,每位患者平均引出 30 个 NMS 中的 11 个,其中平均有 4.8 个在临床记录中报告(44%)。最常见的 NMS 是自主的(特别是泌尿系统)。Hr-QoL 评分与自主功能障碍(r = 0.84;特别是泌尿系统和胃肠道症状)、情绪(r = 0.74)、疲劳(r = 0.74)、睡眠问题(夜间 r = 0.55;日间嗜睡 r = 0.65)、疼痛(r = 0.56)和精神病(r = 0.55,均 p < 0.0001)相关最强,其次是 UPDRS 运动评分(r = 0.48,p < 0.0001)。更大的运动波动(r = 0.57)和运动障碍(r = 0.43,均 p < 0.0001)也与较差的 Hr-QoL 相关。在多变量分析中,抑郁与 Hr-QoL 相关性最强(调整后的 R²= 0.53,p = 0.005),其次是疲劳、体温调节、胃肠道和心血管自主功能(特别是直立性低血压)、日间嗜睡和泌尿系统问题。这项研究表明,自主功能障碍、精神并发症、疼痛、疲劳和睡眠问题是 Hr-QoL 较差的主要原因。然而,尽管精神问题越来越多地被记录下来,但许多症状(特别是那些可能被认为尴尬或无关的症状)仍未得到充分报告。

相似文献

1
What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them?帕金森病患者最重要的非运动症状有哪些?我们是否遗漏了这些症状?
Mov Disord. 2010 Nov 15;25(15):2493-500. doi: 10.1002/mds.23394.
2
Nonmotor symptoms in nursing home residents with Parkinson's disease: prevalence and effect on quality of life.养老院帕金森病患者的非运动症状:患病率及其对生活质量的影响。
J Am Geriatr Soc. 2013 Oct;61(10):1714-21. doi: 10.1111/jgs.12458. Epub 2013 Oct 1.
3
Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.帕金森病空肠内左旋多巴输注:一项关于对非运动症状和生活质量影响的多中心试点研究
Mov Disord. 2009 Jul 30;24(10):1468-74. doi: 10.1002/mds.22596.
4
Validation of the MDS-UPDRS Part I for nonmotor symptoms in Parkinson's disease.验证 MDS-UPDRS 第一部分在帕金森病非运动症状中的应用。
Mov Disord. 2012 Jan;27(1):79-83. doi: 10.1002/mds.23939. Epub 2011 Sep 13.
5
Nonmotor symptoms of Parkinson's disease.帕金森病的非运动症状
Expert Rev Neurother. 2006 Dec;6(12):1811-22. doi: 10.1586/14737175.6.12.1811.
6
The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: an international study using the nonmotor symptoms questionnaire.帕金森病非运动症状向医护人员隐瞒情况:使用非运动症状问卷的国际研究。
Mov Disord. 2010 Apr 30;25(6):704-9. doi: 10.1002/mds.22868.
7
Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease.帕金森病非运动症状对健康相关和感知生活质量的影响。
J Neurol Sci. 2013 Sep 15;332(1-2):136-40. doi: 10.1016/j.jns.2013.07.005. Epub 2013 Jul 25.
8
International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study.帕金森病首个综合性自我完成非运动症状问卷的国际多中心试点研究:NMSQuest研究。
Mov Disord. 2006 Jul;21(7):916-23. doi: 10.1002/mds.20844.
9
Motor laterality asymmetry and nonmotor symptoms in Parkinson's disease.帕金森病的运动侧偏性和非运动症状。
Mov Disord. 2010 Jan 15;25(1):70-5. doi: 10.1002/mds.22896.
10
Nocturnal sleep disturbances and daytime dysfunction in patients with Parkinson's disease and in their caregivers.帕金森病患者及其照料者的夜间睡眠障碍和日间功能障碍
Parkinsonism Relat Disord. 2004 Mar;10(3):157-68. doi: 10.1016/j.parkreldis.2003.11.002.

引用本文的文献

1
Feasibility and Acceptability of Intervention and Trial Procedures of the UCL Live Well With Parkinson's Self-Management Toolkit.伦敦大学学院帕金森自我管理工具包干预措施及试验程序的可行性与可接受性
Parkinsons Dis. 2025 Aug 21;2025:2804226. doi: 10.1155/padi/2804226. eCollection 2025.
2
A Theoretical and Practical Analysis of Membrane Protein Genes Altered in Neutrophils in Parkinson's Disease.帕金森病中性粒细胞中膜蛋白基因改变的理论与实践分析
Curr Issues Mol Biol. 2025 Jun 13;47(6):459. doi: 10.3390/cimb47060459.
3
Behavioral Compared With Drug Therapy for Overactive Bladder Symptoms in Parkinson Disease: A Randomized Noninferiority Trial.
帕金森病膀胱过度活动症症状的行为疗法与药物疗法比较:一项随机非劣效性试验。
JAMA Neurol. 2025 Jul 14. doi: 10.1001/jamaneurol.2025.1904.
4
Combination treatment with acupoint therapy and conventional medication for non-motor symptoms in Parkinson's disease: a systematic review and meta-analysis.穴位疗法与传统药物联合治疗帕金森病非运动症状的系统评价与Meta分析
Front Neurol. 2025 May 22;16:1381500. doi: 10.3389/fneur.2025.1381500. eCollection 2025.
5
How leaky is the gut in Parkinson's disease?帕金森病患者的肠道屏障有多渗漏?
EBioMedicine. 2025 Jun 3;117:105796. doi: 10.1016/j.ebiom.2025.105796.
6
Effectiveness of electrical stimulation with conservative treatment for lower urinary tract symptoms in Parkinson's disease: A three-armed randomized controlled trial protocol.电刺激联合保守治疗对帕金森病下尿路症状的有效性:一项三臂随机对照试验方案
Contemp Clin Trials Commun. 2025 Mar 29;45:101480. doi: 10.1016/j.conctc.2025.101480. eCollection 2025 Jun.
7
Progress and prospects of Parkinson's disease with depression research: A global bibliometric analysis based on CiteSpace.帕金森病伴发抑郁研究的进展与展望:基于CiteSpace的全球文献计量分析
Medicine (Baltimore). 2025 Feb 14;104(7):e41537. doi: 10.1097/MD.0000000000041537.
8
Changes in sensor recorded activity patterns and neuropsychiatric symptoms after deep brain stimulation for Parkinson's disease: 5 case reports.帕金森病患者接受脑深部电刺激后传感器记录的活动模式及神经精神症状的变化:5例病例报告
BMC Neurol. 2025 Jan 17;25(1):25. doi: 10.1186/s12883-025-04030-w.
9
Copper homeostasis and neurodegenerative diseases.铜稳态与神经退行性疾病
Neural Regen Res. 2025 Nov 1;20(11):3124-3143. doi: 10.4103/NRR.NRR-D-24-00642. Epub 2024 Nov 13.
10
Assessments scales for the evaluation of health-related quality of life in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy: a systematic review.帕金森病、进行性核上性麻痹和多系统萎缩中与健康相关生活质量评估量表的系统评价
Front Psychol. 2024 Sep 10;15:1438830. doi: 10.3389/fpsyg.2024.1438830. eCollection 2024.